首页> 外文期刊>Journal of Medicinal Chemistry >4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies
【24h】

4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies

机译:4-芳基苯磺酰胺作为人类碳酸酐酶抑制剂(hCAIs):钯纳米催化剂介导的Suzuki-Miyaura反应的合成,酶抑制和X射线晶体学研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Benzenesulfonamides bearing various substituted (hetero)aryl rings in the para-position were prepared by palladium nanoparticle-catalyzed Suzuki-Miyaura cross-coupling reactions and evaluated as human carbonic anhydrase (hCA, EC 4.2.1.1) inhibitors against isoforms hCA I, II, IX, and XII. Most of the prepared sulfonamides showed low inhibition against hCA I isoform, whereas the other cytosolic isoenzyme, hCA II, was strongly affected. The major part of these new derivatives acted as potent inhibitors of the tumor-associated isoform hCA XII. An opposite trend was observed for phenyl, naphthyl, and various heteroaryl substituted benzenesulfonamides which displayed subnanomolar hCA IX inhibition while poorly inhibiting the other tumor-associated isoform hCA XII. The inhibition potency and influence of the partially restricted arylaryl bond rotation on the activity/selectivity were rationalized by means of X-ray crystallography of the adducts of hCA II with several 4-arylbenzenesulfonamides.
机译:通过钯纳米粒子催化的Suzuki-Miyaura交叉偶联反应制备对位带有各种取代的(杂)芳基环的苯磺酰胺,并将其评估为针对同工型hCA I,II, IX和XII。大多数制备的磺酰胺类药物对hCA I同工型均显示出较低的抑制作用,而其他胞质同工酶hCA II受强烈影响。这些新衍生物的主要部分是与肿瘤相关的亚型hCA XII的有效抑制剂。对于苯基,萘基和各种杂芳基取代的苯磺酰胺,观察到相反的趋势,它们显示出亚纳摩尔的hCA IX抑制作用,而抑制其他与肿瘤相关的同种型hCA XII的作用较弱。通过hCA II与几种4-芳基苯磺酰胺的加合物的X射线晶体学分析,合理化了抑制能力和部分限制的芳基芳基键旋转对活性/选择性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号